[From Pharma Times, August 15, 2018] “ViiV Healthcare and Janssen have unveiled positive headline data from a late-stage trial of their injectable two-drug regimen for the treatment of HIV.” For more, click here.
ViiV, Janssen’s two-drug HIV regimen hits PhIII targets Read More »
[From aidsmap, August 13, 2018] “Pre-exposure prophylaxis (PrEP) use is accelerating among men who have sex with men and transgender women in two south-east Asian countries where it is receiving funding and government support, the 22nd International AIDS Conference (AIDS 2018) conference heard two weeks ago.” For more, click here.
PrEP use taking off in Thailand and Vietnam Read More »
[From CBC, August 13, 2018] “The number of newly diagnosed HIV cases in Saskatchewan has increased for a third straight year. There were 177 new cases of HIV diagnosed in the province in 2017, up from 170 the year before.” For more, click here.
New HIV diagnoses in Sask. increase for 3rd straight year Read More »
[From University of New South Wales Newsroom, July 17, 2018] “Results from a large study of HIV transmission risk among homosexual male couples with differing HIV status were today published in The Lancet HIV. The study, led by the Kirby Institute at UNSW Sydney and called Opposites Attract, contributes to global evidence demonstrating a HIV-positive person on
HIV treatment-as-prevention is effective in homosexual male couples, study finds Read More »
[From Council on Foreign Relations, July 17, 2018] “Next week, some 15,000 participants from around the world will come together to discuss progress on responding to the HIV epidemic. The 22nd International AIDS Conference is an opportunity to reflect on how far we have come, but also to chart our way forward. This year is a
To End the HIV Epidemic, Focus on Sexual Violence Prevention Read More »
